«A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis». Nat Genet35 (4): 349-56. Dec 2003. PMID14608357. doi:10.1038/ng1268.
«A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis». Nat Genet35 (4): 349-56. Dec 2003. PMID14608357. doi:10.1038/ng1268.